The global frontotemporal dementia therapeutics market is experiencing significant expansion. This phenomenon can be linked to a rising prevalence of frontotemporal dementia, coupled with innovations in research and development of novel therapies. The market is fueled by a combination of factors, including an aging population, rising healthcare exp